SEC Form 4 · accession 0001209191-16-135900
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Bluth
Officer — EVP of Investor Relations
Period of report
Aug 5, 2016
Accepted (ET)
Aug 8, 2016 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $24.14 | Aug 5, 2016 | A | 40,000 | A | — | Aug 5, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option vests according to the following schedule: 1/4th of the shares vest on 08/01/2017; and 1/36th of the remaining shares vest at the end of each month over the next 36 months.